av/universal-ibogaine--big.svg

TSX:IBO

Universal Ibogaine Inc.

  • Stock

Last Close

0.01

24/09 13:30

Volume Today

3.01K

Avg: 43.86K

PE Ratio

−1.35

PFCF: −1.58

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '17
Mar '18
Mar '19
Mar '20
Jul '21
Jul '22
average inventory
average payables
147.96K
-
233.85K
58.05%
average receivables
14.73K
-
16.50K
11.97%
19.78K
19.92%
74.34K
275.77%
172.25K
131.69%
book value per share
0.03
-
0.02
30.53%
0.01
60.08%
0.02
193.19%
0.02
9.68%
capex per share
-0.00
-
-0.00
-
capex to depreciation
-6.00
-
-0.36
-
capex to operating cash flow
0.01
-
0.02
-
capex to revenue
-0.09
-
cash per share
0.01
-
0.02
310.63%
0.01
70.66%
0.00
81.46%
0.00
244.34%
days of inventory on hand
days payables outstanding
days sales outstanding
78.74
-
debt to assets
0.10
-
0.28
167.79%
debt to equity
0.14
-
0.44
216.44%
dividend yield
0.02
-
earnings yield
-0.24
-
-0.06
75.00%
-0.06
6.25%
-0.19
208.91%
-1.62
736.74%
enterprise value
-387.75K
-
1.68M
534.12%
1.46M
13.09%
1.82M
24.44%
20.30M
1,015.01%
7.51M
63.01%
enterprise value over ebitda
26.32
-
-43.20
264.14%
2.85K
6,704.42%
-5.39
100.19%
-1.63
69.78%
ev to operating cash flow
-5.25
-
-20.32
286.71%
-14.92
26.56%
-6.25
58.15%
-1.73
72.26%
ev to sales
7.01
-
free cash flow per share
-0.03
-
-0.01
76.62%
-0.01
42.27%
-0.03
148.65%
-0.02
8.09%
free cash flow yield
-0.18
-
-0.04
76.62%
-0.07
51.16%
-0.16
148.65%
-0.68
320.15%
graham net net
0.00
-
0.02
308.18%
0.01
65.98%
-0.01
200.49%
-0.01
21.25%
graham number
0.16
-
0.07
58.33%
0.04
36.82%
0.13
200.95%
0.16
28.58%
income quality
0.78
-
0.73
6.47%
1.03
40.51%
0.84
18.50%
0.41
50.87%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-255.45
-
7.34
102.87%
interest debt per share
0.00
-
0.01
186.48%
inventory turnover
invested capital
0.14
-
0.44
216.44%
market cap
1.74M
-
1.67M
3.88%
1.89M
13.50%
20.03M
958.16%
6.50M
67.56%
net current asset value
400K
-
295.22K
26.19%
197.12K
33.23%
93.62K
52.51%
-146.33K
256.30%
-1.36M
828.11%
net debt to ebitda
-0.81
-
6.05
845.43%
-113.64
1,977.65%
-0.07
99.94%
-0.22
208.54%
net income per share
-0.04
-
-0.01
75%
-0.01
0%
-0.03
208.91%
-0.06
83.04%
operating cash flow per share
-0.03
-
-0.01
76.62%
-0.01
40.51%
-0.03
151.76%
-0.02
10.08%
payables turnover
receivables turnover
4.64
-
research and ddevelopement to revenue
0.38
-
return on tangible assets
-1.27
-
-0.45
64.53%
-1.01
124.61%
-0.97
4.51%
-1.66
71.49%
revenue per share
0.01
-
roe
-1.38
-
-0.50
64.01%
-1.25
150.50%
-1.31
5.36%
-2.66
102.65%
roic
0.22
-
-0.17
179.30%
0.01
103.52%
-1.15
19,059.68%
0.09
107.58%
sales general and administrative to revenue
4.27
-
shareholders equity per share
0.03
-
0.02
30.53%
0.01
60.08%
0.02
193.19%
0.02
9.68%
stock based compensation to revenue
0.84
-
tangible asset value
400K
-
295.22K
26.19%
197.12K
33.23%
94.89K
51.86%
2.94M
3,002.41%
3.94M
33.94%
tangible book value per share
0.03
-
0.02
30.53%
0.01
60.08%
0.02
193.19%
0.02
9.68%
working capital
400K
-
295.22K
26.19%
197.12K
33.23%
93.62K
52.51%
-86.33K
192.21%
379.61K
539.74%

All numbers in (except ratios and percentages)